Effectiveness and Safety of the FloTrac Vigileo® System for Hemodynamic Monitoring in Major and High-Risk Surgeries

  • Luiz Henrique Picolo Furlan Unimed Paraná
  • Ricardo Simões Unimed do Brasil
  • Junior Vitorino Fandim Unimed do Brasil
  • Janaina Cardo Nunes Marinho Unimed do Brasil
  • Julia Simões Correa Galendi Unimed do Brasil

Abstract

Introduction: Perioperative fluid management may influence clinical outcomes. Among the available strategies, goal-directed therapy (GDT) has benefits that remain uncertain. Objective: To evaluate the effectiveness and safety of the FloTrac Vigileo® compared with traditional fluid management strategies in major surgeries and/or high-risk patients. Methods: An electronic search was conducted in the Medline/PubMed, EMBASE, and Cochrane Library databases up to June 5, 2025, including randomized controlled trials comparing goal-directed therapy (GDT) with traditional fluid management strategies in surgical patients. Study selection, data extraction, and risk of bias assessment were performed using the Cochrane ROB 1 tool. Meta-analyses were conducted using a random-effects model, with treatment effects expressed as means or relative risks and 95% confidence intervals. Results: We included 47 RCTs that evaluated intraoperative monitoring strategies using the FloTrac Vigileo® system in patients undergoing high-complexity surgeries. The studies focused on abdominal surgery, cardiac surgery, thoracic surgery, neurosurgery, urological surgery, head and neck surgery, gynecological surgery and orthopedic surgery. The FloTrac Vigileo® group demonstrated a reduction in mortality compared with usual care, with a relative risk of 0.79 (95% CI: 0.59 to 1.08). The FloTrac Vigileo® group also showed a reduction in hospital length of stay compared with usual care, with a mean difference of -1.24 days (95% CI: -1.74 to -0.74). ICU length of stay was reduced in the FloTrac Vigileo® group compared with usual care, with a mean difference of -1.04 days (95% CI: -1.75 to -0.33). Conclusion: Goal-directed therapy using the FloTrac Vigileo® system may provide modest clinical benefits in reducing hospital and ICU length of stay in high-complexity surgeries; however, economic evaluations are required to support its incorporation.

     
Published
2026-11-18
How to Cite
Furlan, L. H. P., Simões, R., Vitorino Fandim, J., Marinho, J. C. N., & Galendi, J. S. C. (2026). Effectiveness and Safety of the FloTrac Vigileo® System for Hemodynamic Monitoring in Major and High-Risk Surgeries. Revista Científica Faculdade Unimed, 5(2), 37-68. https://doi.org/10.37688/rcfu.v5i2.258